חזרה לתוצאות החיפוש

A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Thrombocythemia, Essential · Primary Myelofibrosis · Myelofibrosis · Post-polycythemia Vera Myelofibrosis · Post-essential Thrombocythemia Myelofibrosis · Polycythemia Vera

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • University of Michigan ( Site 6000), Ann Arbor, Michigan, United States

    Study coordinator · 734-763-4695

  • DUHS Duke Blood Cancer Center ( Site 6005), Durham, North Carolina, United States

    Study coordinator · 919-668-1608

  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 6007), Columbus, Ohio, United States

    Study coordinator · 888-577-8839

  • UPMC Hillman Cancer Center ( Site 6004), Pittsburgh, Pennsylvania, United States

    Study coordinator · 412-864-6627

  • Royal Prince Alfred Hospital ( Site 1003), Camperdown, New South Wales, Australia

    Study coordinator · +61295155720

  • Royal North Shore Hospital ( Site 1001), St Leonards, New South Wales, Australia

    Study coordinator · +61299264383

  • Sunshine Coast Hematology and Oncology Clinic ( Site 1006), Buderim, Queensland, Australia

    Study coordinator · +61754790000

  • Gold Coast University Hospital-Cancer and Blood Disorders Clinical Trial Team ( Site 1002), Southport, Queensland, Australia

    Study coordinator · +61756872712

  • Royal Adelaide Hospital-Haematology Clinical Trials Unit ( Site 1000), Adelaide, South Australia, Australia

    Study coordinator · +61870740000

  • Monash Health ( Site 1004), Clayton, Victoria, Australia

    Study coordinator · +61395956111

  • Queen Mary Hospital ( Site 1601), Hksar, Hong Kong

  • Azienda Ospedaliera Universitaria Careggi ( Site 2700), Florence, Tuscany, Italy

    Study coordinator · +39 0131 206440

  • Azienda Ospedaliero-Universitaria SS. Antonio e Biagio e Cesare Arrigo ( Site 2703), Alessandria, Italy

    Study coordinator · +39 0131 206440

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola ( Site 2702), Bologna, Italy

    Study coordinator · +390512143044

  • Ospedale di Circolo e Fondazione Macchi Varese ( Site 2701), Varese, Italy

    Study coordinator · +390332393906

  • North Shore Hospital-Department of Haematology ( Site 1401), Auckland, New Zealand

  • Aotearoa Clinical Trials ( Site 1400), Auckland, New Zealand

  • Imperial College Healthcare NHS Trust - Hammersmith Hospital ( Site 3402), London, Hammersmith and Fulham, United Kingdom

    Study coordinator · +442083834340

  • Boston Pilgrim Hospital ( Site 3403), Boston, Lincolnshire, United Kingdom

    Study coordinator · 01205 446311

  • University College London Hospital ( Site 3400), London, London, City of, United Kingdom

    Study coordinator · +442034472528

  • Guy's & St Thomas' NHS Foundation Trust ( Site 3401), London, London, City of, United Kingdom

    Study coordinator · +442071884259
מובילי המחקר

  • Medical Director

    Study Director

    Merck Sharp and Dohme LLC

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)